EU Diabetic Retinopathy Market, Market Segmented by Treatment Type (Anti-Vascular Endothelial Growth Factor, Intraocular Steroid Injection, Laser Surgery, and Vitrectomy), by Indication (Non-Proliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy), and by End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers) Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138184
- Pages: 200
-
Format:
Report Overview
The EU Diabetic Retinopathy market size stood at around USD $1.26 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Diabetic retinopathy is a medical condition which damages the retina and leads to blindness if untreated or undiagnosed. The degree of treatment of diabetic retinopathy varies according to various stages of the disease and is mainly prioritized to curb the epidemic at its initial stage
Market Drivers
Factors of market drivers are, the adoption of sedentary lifestyles and changes in food habits is driving the demand of the market. An increasing number of diabetic patients is also considered to be a significant factor propelling the growth of the European diabetic retinopathy market. Growing awareness over the availability of drugs for different diseases is accelerating the demand of the market. Other growth enhancing factors are government initiatives, abundant R&D activities, and skill set enhancement of healthcare providers. Such supportive initiatives, coupled with rising awareness among patients, are anticipated to result in lucrative growth
1. EU Diabetic Retinopathy Market Overview.............................
A. Market Size
2. EU Diabetic Retinopathy Market Growth Drivers..........
A. Adoption of sedentary lifestyles and changes in food habit
B. Increasing number of diabetic patients
C. Growing R&D and government initiatives
3. EU Diabetic Retinopathy Market Segmentation.
A. By Treatment Type
I. Anti-Vascular Endothelial Growth Factor
II. Intraocular Steroid Injection
III. Laser Surgery
IV. Vitrectomy
B. By Indication
I. Non-Proliferative Diabetic Retinopathy
II. Proliferative Diabetic Retinopathy
C. By End Users
I. Hospitals
II. Ophthalmic Clinics
III. Ambulatory Surgical Centers
4. EU Diabetic Retinopathy Major Market Share....................................
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Bayer AG, Company overview, Product & Services, Strategies & Financials
B. Pfizer, Inc Company overview, Product & Services, Strategies & Financials
C. Roche Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
